Related Experiment Video
Updated: Jul 18, 2026

A Reference Broth Microdilution Method for Dalbavancin In Vitro Susceptibility Testing of Bacteria that Grow Aerobically
Published on: September 9, 2015
Single-Dose Dalbavancin: A Review in Acute Bacterial Skin and Skin Structure Infections
1Springer, Private Bag 65901, Mairangi Bay 0754, Auckland, New Zealand. demail@springer.com.
Single-dose dalbavancin effectively treats acute bacterial skin infections in adults, showing comparable efficacy and tolerability to the two-dose regimen. This offers a convenient and promising alternative for ABSSSI treatment.
Area of Science:
- Pharmacology
- Infectious Diseases
- Dermatology
Background:
- Dalbavancin, an intravenous lipoglycopeptide antibiotic, was initially approved for acute bacterial skin and skin structure infections (ABSSSI) using a two-dose regimen.
- Recent approvals now include a single-dose regimen for ABSSSI treatment in adult patients.
Purpose of the Study:
- To review the pharmacological properties of intravenous dalbavancin.
- To evaluate the clinical efficacy and tolerability of the single-dose dalbavancin regimen for ABSSSI in adults.
Main Methods:
- This study is a narrative review of existing literature.
- It focuses on pharmacological data, clinical trial results, and adverse event profiles of single-dose dalbavancin for ABSSSI.
Main Results:
- Single-dose dalbavancin demonstrated non-inferior early clinical response compared to the two-dose regimen.
- Clinical success rates at 14 and 28 days were similar between the single- and two-dose regimens, regardless of baseline pathogen.
- The single-dose regimen was generally well-tolerated with low adverse event rates.
Conclusions:
- Single-dose dalbavancin is an effective and well-tolerated option for treating adult ABSSSI.
- Its favorable pharmacokinetic profile supports convenient single-dose administration.
- Dalbavancin presents a valuable alternative to conventional antibiotics for ABSSSI.
More Related Videos
09:29In Vivo Investigation of Antimicrobial Blue Light Therapy for Multidrug-resistant Acinetobacter baumannii Burn Infections Using Bioluminescence Imaging
Published on: April 28, 2017
10:45Deep Dermal Injection As a Model of Candida albicans Skin Infection for Histological Analyses
Published on: June 13, 2018
Related Concept Videos
Determination of Multiple Dosing Parameters: Steady-State, Minimum and Maximum Concentrations
Acute Pyelonephritis II: Diagnostic Studies and Management
Antimicrobial Effectiveness
The Skin Microbiota
Staphylococcal Skin Infections
Acne Infection